These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1616213)

  • 1. Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading.
    Kim SG; Mannino MM; Chou R; Roth S; Roth JA; Desai B; Ferrick KJ; Fisher JD
    Ann Intern Med; 1992 Aug; 117(3):197-201. PubMed ID: 1616213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone.
    Mostow ND; Vrobel TR; Noon D; Rakita L
    Circulation; 1986 Jun; 73(6):1231-8. PubMed ID: 3698254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias.
    Kerin NZ; Blevins RD; Frumin H; Faitel K; Rubenfire M
    Am J Cardiol; 1985 Jan; 55(1):89-91. PubMed ID: 3966403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
    Hohnloser SH; Meinertz T; Dammbacher T; Steiert K; Jähnchen E; Zehender M; Fraedrich G; Just H
    Am Heart J; 1991 Jan; 121(1 Pt 1):89-95. PubMed ID: 1985383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
    Russo AM; Beauregard LM; Waxman HL
    Am J Cardiol; 1993 Dec; 72(18):1395-9. PubMed ID: 8256733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
    Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
    J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone treatment in patients with ventricular arrhythmias.
    Prystowsky EN; Heger JJ; Miles WM; Zipes DP
    Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone attenuates the proarrhythmic effects of dobutamine in patients with advanced congestive heart failure.
    Tsagalou EP; Gounopoulos P; Terrovitis JV; Drakos SG; Katsaros FT; Kaldara EE; Alexopoulos GP; Anastasiou-Nana MI
    Hellenic J Cardiol; 2009; 50(3):193-8. PubMed ID: 19465360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients.
    Girgis I; Gualberti J; Langan L; Malek S; Mustaciuolo V; Costantino T; McGinn TG
    Chest; 1997 Sep; 112(3):646-53. PubMed ID: 9315796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia.
    Kalbfleisch SJ; Williamson B; Man KC; Vorperian V; Hummel JD; Hasse C; Strickberger SA; Calkins H; Langberg JJ; Morady F
    J Am Coll Cardiol; 1993 Nov; 22(6):1723-9. PubMed ID: 8227846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy].
    Rosenbaum M; Posse R; Sgammini H; Núñez Burgos J; Chiale PA; Pastori JD; González Zuelgaray J; Brunetto JF; Califano JE
    Arch Inst Cardiol Mex; 1987; 57(4):325-30. PubMed ID: 2445316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs.
    Nagasawa Y; Chen J; Hashimoto K
    J Pharmacol Sci; 2005 Mar; 97(3):393-9. PubMed ID: 15764841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral amiodarone in high-risk ventricular arrhythmias.
    Toruncha A; García-Barreto D; González-Gómez A; Llerena L; Sellén J; Ramos-Emperador C; Cabrera-Alonso C; Hernández-Cañero A
    Cor Vasa; 1982; 24(5):354-64. PubMed ID: 7172689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy.
    Kadish AH; Chen RF; Schmaltz S; Morady F
    J Am Coll Cardiol; 1990 Nov; 16(5):1240-5. PubMed ID: 1699982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.